165 related articles for article (PubMed ID: 3260379)
1. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Pileblad E; Carlsson A
Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379
[TBL] [Abstract][Full Text] [Related]
2. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
Sundström E; Jonsson G
Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
[TBL] [Abstract][Full Text] [Related]
4. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
Jonsson G; Nwanze E; Luthman J; Sundström E
Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
Pileblad E; Fornstedt B; Clark D; Carlsson A
J Pharm Pharmacol; 1985 Oct; 37(10):707-11. PubMed ID: 2416901
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
Hallman H; Lange J; Olson L; Strömberg I; Jonsson G
J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
9. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
Reinhard JF; Daniels AJ; Viveros OH
Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the possible dopaminergic toxicity of 1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine, an isomer to the neurotoxin MPTP.
Nilsson K; Hallberg A; Pileblad E; Tunek A
Pharmacol Toxicol; 1991 Jul; 69(1):38-42. PubMed ID: 1682909
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
Araki T; Kumagai T; Matsubara M; Ido T; Imai Y; Itoyama Y
Metab Brain Dis; 2000 Sep; 15(3):193-201. PubMed ID: 11206588
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
Muramatsu Y; Kurosaki R; Mikami T; Michimata M; Matsubara M; Imai Y; Kato H; Itoyama Y; Araki T
Metab Brain Dis; 2002 Sep; 17(3):169-82. PubMed ID: 12322787
[TBL] [Abstract][Full Text] [Related]
13. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches.
Hara K; Tohyama I; Kimura H; Fukuda H; Nakamura S; Kameyama M
Brain Res; 1987 May; 410(2):371-4. PubMed ID: 3297254
[TBL] [Abstract][Full Text] [Related]
14. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
Sundström E; Strömberg I; Tsutsumi T; Olson L; Jonsson G
Brain Res; 1987 Mar; 405(1):26-38. PubMed ID: 2882814
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain.
Markstein R; Lahaye D
Eur J Pharmacol; 1984 Nov; 106(2):301-11. PubMed ID: 6335691
[TBL] [Abstract][Full Text] [Related]
16. Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain.
Pileblad E; Carlsson A
Neuropharmacology; 1985 Jul; 24(7):689-92. PubMed ID: 3875057
[TBL] [Abstract][Full Text] [Related]
17. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents.
Fuller RW; Steranka LR
Life Sci; 1985 Jan; 36(3):243-7. PubMed ID: 3871244
[TBL] [Abstract][Full Text] [Related]
18. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
19. The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.
Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
Neuropharmacology; 1986 Aug; 25(8):897-904. PubMed ID: 3022182
[TBL] [Abstract][Full Text] [Related]
20. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
